FDA Stakeholders Meeting For Chronic Fatigue Syndrome II: Barriers, Breakthroughs and Possibilities For Drug Development
Bernard Munos' daunting but ultimately inspiring talk on what the ME/CFS field needed to do to attract pharma suggested we may be closer than we think.Are the Canadian Consensus and International Consensus Criteria Broken? Study Suggests Both May Select for More Psychiatric Patients
A recent study suggests that while the ICC does select for more ME/CFS-like patients it also selects for patients with more psychiatric disorders.
Patients Give FDA the Scoop on ME/CFS in First Day of FDA Stakeholder Meeting
“There’s an unmet medical need right here and there has been for a long time” Bob Miller The first day of the FDA Stakeholders Meeting was like an patient/FDA roundtable session focusing on what symptoms are worst and what treatments worked best....
End of an Era: Kim McCleary Steps Down After 22 Years at the Helm of the CFIDS Association of America (CAA)
End of an era; Kim McCleary steps down after 22 years at the helm of the CFIDS Association of America (CAA)StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
